JW (Cayman) Therapeutics Co. Ltd (2126.HK)

HKD 1.3

(0.0%)

Inventory Summary of JW (Cayman) Therapeutics Co. Ltd

  • JW (Cayman) Therapeutics Co. Ltd's latest annual inventory in 2023 was 34.77 Million CNY , down -13.4% from previous year.
  • JW (Cayman) Therapeutics Co. Ltd's latest quarterly inventory in 2024 Q2 was 50.6 Million CNY , down 0.0% from previous quarter.
  • JW (Cayman) Therapeutics Co. Ltd reported annual inventory of 40.15 Million CNY in 2022, up 27.89% from previous year.
  • JW (Cayman) Therapeutics Co. Ltd reported annual inventory of 31.4 Million CNY in 2021, up 3188.17% from previous year.
  • JW (Cayman) Therapeutics Co. Ltd reported quarterly inventory of 44.29 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • JW (Cayman) Therapeutics Co. Ltd reported quarterly inventory of 34.77 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of JW (Cayman) Therapeutics Co. Ltd (2023 - 2018)

Historical Annual Inventory of JW (Cayman) Therapeutics Co. Ltd (2023 - 2018)

Year Inventory Inventory Growth
2023 34.77 Million CNY -13.4%
2022 40.15 Million CNY 27.89%
2021 31.4 Million CNY 3188.17%
2020 955 Thousand CNY 0.0%
2019 - CNY 0.0%
2018 - CNY 0.0%

Peer Inventory Comparison of JW (Cayman) Therapeutics Co. Ltd

Name Inventory Inventory Difference
Uni-Bio Science Group Limited 36.39 Million HKD 4.435%
CK Life Sciences Int'l., (Holdings) Inc. 1.2 Billion HKD 97.113%